Mielóma multiplex: vizsgálatok itt: Németország
63 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleBEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma
- Where
- Hamburg
- Életkor
- 18 év and over
- People
- 45
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT07564219 - 3. fázisFut, nem toborozA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Chemnitz, Cologne, Dresden, Hamburg, Hanover, Jena, Luebeck, Mainz, Wuerzburg
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - 3. fázisTaking peopleA Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
- Where
- Greifswald, Luebeck, Wuerzburg
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06932562 · EU 2024-519827-16-00 - 1. fázisTaking peopleA Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- Where
- Cologne, Heidelberg, Wuerzburg
- Életkor
- 18 év and over
- People
- 187 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06153251 · EU 2023-506003-26-00 - No phaseNot yet taking people in NémetországReal-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Takeda
See details and how to joinNCT05879757 - No phaseNot yet taking people in NémetországExercise Therapy for Multiple Myeloma Patients
- Where
- Heidelberg
- Életkor
- 18 év to 75 év
- People
- 71
- Run by
- University Hospital Heidelberg
See details and how to joinNCT07388147 - No phaseTaking peopleTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Where
- Essen
- People
- 50 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06357754 - No phaseTaking peopleFall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients
- Where
- Heidelberg
- Életkor
- 18 év and over
- People
- 60
- Run by
- University Hospital Heidelberg
See details and how to joinNCT07044427 - 2. fázisTaking peopleGMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5
- Where
- Berlin, Chemnitz, Dresden, Duesseldorf, Freiburg im Breisgau, Hamburg, Heidelberg, Kiel, Munich, Wuerzburg
- Életkor
- 18 év to 70 év
- People
- 160
- Run by
- University of Heidelberg Medical Center
See details and how to joinNCT05695508 · EU 2024-517382-17-00 - No phaseTaking peopleGMMG Multiple Myeloma Registry
- Where
- Berlin, Bielefeld, Bochum, Bonn, Chemnitz, Cologne, Darmstadt, Düsseldorf, Erlangen, Essen, Frankfurt am Main, Giessen, Hagen, Hamburg, Heidelberg, Heilbronn, Homburg, Kaiserslautern, Koblenz, Lebach, Mainz, Mannheim, Marburg, Mönchengladbach, Regensburg, Schwäbisch Hall, Siegburg, Speyer, Trier, Tübingen
- Életkor
- 18 év and over
- People
- 999
- Run by
- Prof. Dr. Hartmut Goldschmidt
See details and how to joinNCT07111884 - 3. fázisTaking peopleA randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma (GMMG-HD9/DSMM XVIII-trial)
- Where
- Aachen, Augsburg, Bad Saarow, Bayreuth, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Chemnitz, Cottbus, Darmstadt, Dessau-Rosslau, Dortmund, Dresden, Duesseldorf, Duisburg, Eschweiler, Essen, Flensburg, Frankfurt, Frankfurt Am Main, Freiburg im Breisgau, Greifswald, Hagen, Halle (Saale), Hamburg, Hannover, Heidelberg, Heilbronn, Homburg, Jena, Kaiserslautern, Karlsruhe, Kempten (Allgau), Kiel, Koblenz, Lebach, Leipzig, Ludwigshafen Am Rhein, Luebeck, Magdeburg, Mainz, Mannheim, Marburg, Meschede, Moenchengladbach, Munich, Mutlangen, Oldenburg, Osnabrueck, Paderborn, Regensburg, Schwaebisch Hall, Siegburg, Speyer, Stuttgart, Tuebingen, Ulm, Villingen-Schwenningen, Wuerzburg
- Életkor
- 18 év and over
- People
- 451 worldwide
- Run by
- Universitaetsklinikum Heidelberg AöR
See details and how to join2023-507402-13-00 - No phaseNot yet taking people in NémetországDeveloping a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
- Where
- Berlin, Garmisch-Partenkirchen
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Medical University Innsbruck
See details and how to joinNCT06821880 - 2/3. fázisFut, nem toborozExpression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients
- Where
- Aachen, Aschaffenburg, Berlin, Bielefeld, Dachau, Deggendorf, Dortmund, Essen, Frankfurt Am Main, Greifswald, Hamburg, Herne, Jena, Kassel, Lübeck, Muenster, Munich, Nuremberg, Oldenburg, Paderborn, Siegen, Traunstein, Wuerzburg
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- University Hopsital Schleswig Holstein Campus Lübeck
See details and how to joinNCT05665140 · EU 2022-500453-16-00